Evidence map›Paper›PMID 34711132›Full record

ArticleInfectious diseases (London, England)2022

Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19-analysis of a paediatric part of Polish register SARSTer.

Anna Mania, Maria Pokorska-Śpiewak, Magdalena Figlerowicz, Małgorzata Pawłowska, Katarzyna Mazur-Melewska, Kamil Faltin, Ewa Talarek, Konrad Zawadka, Anna Dobrzeniecka, Przemysław Ciechanowski and 21 more

Abstract readMulticenter Study
In one paragraph

Article in Infectious diseases (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Functional status of hospitalized pediatric patients with COVID-19 in southern Brazil: a prospective cohort study.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Anna ManiaDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0003-0141-2560
Maria Pokorska-ŚpiewakDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-7783-6904
Magdalena FiglerowiczDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0003-4731-0658
Małgorzata PawłowskaDepartment of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.ORCID 0000-0002-6044-0425
Katarzyna Mazur-MelewskaDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0003-2695-4649
Kamil FaltinDepartment of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0002-5200-7285
Ewa TalarekDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-3466-0782
Konrad ZawadkaDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Anna DobrzenieckaDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
Przemysław CiechanowskiDepartment of Paediatrics and Infectious Diseases, Regional Hospital in Szczecin, Szczecin, Poland.
Joanna Łasecka-ZadrożnaDepartment of Paediatrics and Infectious Diseases, Regional Hospital in Szczecin, Szczecin, Poland.
Józef RudnickiDepartment of Paediatrics and Infectious Diseases, Regional Hospital in Szczecin, Szczecin, Poland.
Barbara HasiecDepartment of Children's Infectious Diseases, Provincial Jan Boży Hospital in Lublin, Lublin, Poland.
Martyna StaniDepartment of Children's Infectious Diseases, Provincial Jan Boży Hospital in Lublin, Lublin, Poland.
Paulina Frańczak-ChmuraDepartment of Children's Infectious Diseases, Provincial Jan Boży Hospital in Lublin, Lublin, Poland.
Izabela ZaleskaDepartment of Paediatrics and Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0002-3762-3901
Leszek SzenbornDepartment of Paediatrics and Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0001-6574-8229
Paulina HoreckaDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland.
Artur SulikDepartment of Pediatric Infectious Diseases, Medical University of Bialystok, Bialystok, Poland.ORCID 0000-0002-8391-4793
Barbara SzczepańskaCollegium Medicum Jan Kochanowski University, Kielce, Poland.ORCID 0000-0002-3334-039X
Ilona Pałyga-BysieckaCollegium Medicum Jan Kochanowski University, Kielce, Poland.ORCID 0000-0002-5781-0886
Izabela Kucharek2nd Department of Paediatrics, Centre of Postgraduate Medical Education, Warsaw, Poland.
Adam Sybilski2nd Department of Paediatrics, Centre of Postgraduate Medical Education, Warsaw, Poland.ORCID 0000-0003-2389-277X
Małgorzata Sobolewska-PilarczykDepartment of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
Urszula DryjaDepartment of Paediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland.
Ewa Majda-StanisławskaDepartment of Paediatric Infectious Diseases, Medical University of Lodz, Lodz, Poland.ORCID 0000-0002-7178-5293
Sławomira NiedźwieckaDepartment of Paediatric Infectious Diseases, Pomeranian Center of Infectious Diseases and Tuberculosis in Gdańsk, Gdańsk, Poland.
Ernest KucharDepartment of Paediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-7883-2427
Bolesław KalickiDepartment of Paediatrics, Paediatric Nephrology and Allergology, Military Institute of Medicine, Warsaw, Poland.ORCID 0000-0003-1606-5100
Anna GorczycaThe Ward of Pediatric Infectious Diseases and Hepatology, The John Paul II Hospital in Krakow, Krakow, Poland.ORCID 0000-0002-5087-270X
Magdalena MarczyńskaDepartment of Children's Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-5731-6346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough COVID-19 is associated with a mild course in children, a certain proportion requires admission to hospital due to SARS-CoV-2 infection and coexisting diseases. The prospective multicenter study aimed to analyze clinical factors influencing the length of the hospital stay (LoHS) in children with COVID-19.

methodsThe study included 1283 children from 14 paediatric infectious diseases departments with diagnosed SARS-CoV-2 infection. Children were assessed in respective centres regarding indications for admission to hospital and clinical condition. History data, clinical findings, laboratory parameters, treatment, and outcome, were collected in the paediatric SARSTer register. The group of children with a hospital stays longer than seven days was compared to the remaining patients. Parameters with a statistically significant difference were included in further logistic regression analysis.

resultsOne thousand one hundred and ten children were admitted to the hospital, 763 children were hospitalized >24 h and 173 children >7 days. 268 children had comorbidities. Two hundred and eleven children had an additional diagnosis with coinfections present in 135 children (11%). Factors increasing the risk of higher LoHS included pneumonia [odds ratio-OR 3.028; 95% confidence interval-CI (1.878-4.884)], gastrointestinal symptoms [OR = 1.556; 95%CI (1.049-2.322)], or rash [OR = 2.318; 95%CI (1.216-4.418)] in initial clinical findings. Comorbidities [OR = 2.433; 95%CI (1.662-3.563)], an additional diagnosis [OR = 2.594; 95%CI (1.679-4.007)] and the necessity of the empirical antibiotic treatment [OR = 2.834; 95%CI (2.834-6.713)] were further factors related to higher LoHS.

conclusionsThe clinical course of COVID-19 was mild to moderate in most children. Factors increasing the risk of higher LoHS included pneumonia, gastrointestinal symptoms, comorbidities, an additional diagnosis, and the empirical antibiotic treatment.

Indexed as

CoinfectionCOVID-19ChildHospitalsHumansLength of StayPolandProspective StudiesSARS-CoV-2childrenclinical coursecomorbiditiesCOVID-19Length of hospital stayrisk factors

Identifiers

PMID34711132
PMCPMC8567279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.